BREATH HEALTH, Inc.
Adherence to self-monitoring of blood glucose (SMBG) using the common “finger-stick-method” is significantly lower than desired for optimal patient outcomes. It has been reported that adherence rates are in the 20-66% range and is one of the reasons for diabetic complications. There are numerous explanations for this low adherence; however the prominent rationale is that it is an invasive, moderately painful procedure which the individual must endure between 4-12 times a day, every day, for the rest of their lives. There have been reports of a correlation between breath acetone and blood glucose.
Breath Health is developing a technology that specifically detects breath acetone using a nanotechnology approach. This will represent the first truly non-invasive medical device for monitoring blood glucose values. Our technology has been highlighted in international media outlets (e.g. WebMD, FOX News, Diabetes Health, etc.).
Meet the Team
Ronny Priefer, PhD
Chief Executive Officer
Dr. Priefer is a seasoned medicinal and materials chemist with over 20 years of experience in both industry and academics. Dr. Priefer has pioneered a new area of nanotechnology that has led to a wealth of scientific advancements.
Michael Rust, PhD
Chief Technology Officer
Dr. Rust is a skilled engineer in biosensors, bio-instrumentations and medical devices. He has over 15 years of experience in industry and academics.